valproic acid has been researched along with lithium chloride in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (10.34) | 18.2507 |
2000's | 40 (45.98) | 29.6817 |
2010's | 36 (41.38) | 24.3611 |
2020's | 2 (2.30) | 2.80 |
Authors | Studies |
---|---|
Brenstrum, T; Capretta, A; Kim, AJ; Ohnmacht, SA; Panna, E; Werstuck, GH | 1 |
Wang, JF; Young, LT | 1 |
George, B; Kulkarni, SK | 1 |
Woods, CM; Young, LT | 1 |
Lenox, RH; McNamara, RK; Watson, DG; Watterson, JM | 1 |
Barros, HM; Tannhauser, M; Vargas, C | 1 |
Lenox, RH; Watson, DG; Watterson, JM | 1 |
Asghari, V; Reiach, JS; Wang, JF; Young, LT | 1 |
Asghari, V; Rockel, C; Wang, JF; Young, LT | 1 |
Chen, B; Hill, BC; Wang, JF; Young, LT | 1 |
Joffe, RT; MacQueen, GM; Marriott, M; Patelis-Siotis, I; Robb, JC; Young, LT | 1 |
Belmaker, RH; Bersudsky, Y; Hertz, L; Simkin, M; Wolfson, M; Zinger, E | 1 |
Chang, KD; Ketter, TA | 1 |
Ida, S; Nishimoto, A; Shibata, S; Sugawara, A; Takiguchi, Y; Yokota, M; Yoshioka, H | 1 |
Hanstock, CC; Nakashima, TT; O'Donnell, T; Rotzinger, S; Silverstone, PH; Ulrich, M | 1 |
El-Mallahk, RS; Li, R | 1 |
Bottlender, R; Möller, HJ; Rudolf, D; Strauss, A | 1 |
Chen, G; Huang, LD; K Manji, H; Zeng, WZ | 1 |
Bown, CD; Chen, B; Wang, JF; Young, LT | 1 |
Conn, DK; Robillard, M | 1 |
De Sarno, P; Jope, RS; Li, X | 1 |
Kawano, K; Morinobu, S; Tanaka, K; Tsuji, S; Yamawaki, S | 1 |
Asghar, SJ; Dunn, SM; Greenshaw, A; Jurasz, P; Radomski, M; Rotzinger, S; Silverstone, PH; Tanay, VA; Ulrich, ML | 1 |
Chen, PS; Lo, YC; Wang, YT; Yang, YK; Yeh, TL | 1 |
Davanzo, P; Koski, ME; Saldarini, CT; Yehya, N | 1 |
Breier, A; Namjoshi, MA; Risser, R; Shi, L; Tohen, M | 1 |
Altar, CA; Drabik, CE; Laeng, P; Lemire, AL; Mallon, BS; Pitts, RL; Tang, H; Thyagarajan, R; Weiner, A | 1 |
Alevizos, B; Boufidou, F; Christodoulou, GN; Liappas, IA; Nikolaou, C | 1 |
Friedman, E; Hahn, CG; Koneru, R; Levinson, DF; Wang, HY | 1 |
Bazinet, RP; Ertley, RN; Lee, HJ; Rao, JS; Rapoport, SI | 1 |
Kato, N; Kato, T; Kazuno, AA; Munakata, K | 1 |
Amboni, G; Assis, LC; Corrêa, C; Kapczinski, F; Martins, MR; Quevedo, J; Streck, EL | 1 |
Battastini, AM; Bernardi, A; Cimarosti, H; Frozza, RL; Marques, AL; Rocha, E; Salbego, C; Wilot, LC | 1 |
Atbasoglu, EC; Bilgic, A; Goker, C; Olmez, S; Oncu, B; Senturk, V; Tugcu, H | 1 |
Chuang, DM; Liang, MH; Marinova, Z; Yahyavi, A; Yasuda, S | 1 |
Chen, G; Creson, TK; Engel, SR; Hao, Y; Landreth, GE; Maeng, S; Manji, HK; Nekrasova, T; Shen, Y | 1 |
Kilts, JD; Madison, RD; Manji, HK; Marx, CE; Shampine, LJ; Yuan, P | 1 |
Desrosiers, RR; Lamarre, M | 1 |
Coleman, MD; Hill, EJ; Prince, M; Woehrling, EK | 1 |
Chuang, DM; Feng, HL; Leng, Y; Ma, CH; Ren, M; Zhang, J | 1 |
Andreazza, AC; Frey, BN; Giasson, K; Gonçalves, CA; Kapczinski, F; Kauer-Sant'Anna, M; Quevedo, J; Réus, GZ; Ribeiro, L; Salvador, M; Stertz, L; Valvassori, SS; Zanotto, C | 1 |
Adler, JT; Chen, H; Hottinger, DG; Kunnimalaiyaan, M | 2 |
Bain, EE; Cannon, DM; Drevets, WC; Erickson, K; Holmes, MK; Luckenbaugh, DA; Manji, HK; Sahakian, BJ; Snow, J; Zarate, CA | 1 |
Anderson, E; Brown, R; Forster, S; Gibson, GG; Lyon, J; Plant, KE; Plant, N; Simecek, N; Spinks, J; Toms, N | 1 |
Mavrikaki, M; Nomikos, GG; Panagis, G | 1 |
Bundo, M; Iwamoto, K; Kakiuchi, C; Kato, T; Washizuka, S | 1 |
Chan, MK; Di Daniel, E; Ellis, CL; Gallagher, KT; Glover, CP; Grot, E; Maycox, PR; Mudge, AW; Sanderson, TH; Thomas, J; Uney, J; White, JH | 1 |
Kwan, M; Li, PP; Perova, T; Warsh, JJ | 1 |
Choinski, M; Flood, DG; Gasior, M; Marino, MJ | 1 |
Bialer, M; Boris, Y; Dalton, EC; Harwood, AJ; Shimshoni, JA; Watson, P | 1 |
Arent, CO; Ferreira, CL; Fries, GR; Jornada, LK; Kapczinski, F; Moretti, M; Padilha, PT; Quevedo, J; Valvassori, SS | 1 |
Dager, SR; Dunner, DL; Friedman, SD; Kim, JE; Lyoo, IK; Renshaw, PF; Yoon, SJ | 1 |
Akiskal, HS; Berloffa, S; D'Amico, F; Gagliano, A; Masi, G; Millepiedi, S; Mucci, M; Pari, C; Perugi, G; Pfanner, C | 1 |
Arent, CO; Dal-Pizzol, F; Ferreira, CL; Jornada, LK; Mina, F; Moretti, M; Quevedo, J; Steckert, AV; Valvassori, SS | 1 |
Cepa, S; Machado, A; Mesquita, J; Silva, L | 1 |
Baldessarini, RJ | 1 |
Alda, M; O'Donovan, C | 1 |
Dalgard, CL; Doughty, ML; Wynder, C; Zhou, Q | 1 |
Calabrese, JR; Ice, KS; Karayal, ON; Kemp, DE; Pappadopulos, E; Sachs, GS; Siu, CO; Vieta, E | 1 |
Kurita, M; Nakahata, N; Nishino, S; Numata, Y; Ohtomo, K; Sato, T | 1 |
Izumi, T; Kumamoto, H; Minami, M; Ohmura, Y; Tsutsui-Kimura, I; Yamaguchi, T; Yoshida, T; Yoshioka, M | 1 |
Akula, N; Chatterjee, N; Chen, DT; Cheng, A; Cichon, S; Cohen-Woods, S; Craig, I; Farmer, A; Hosang, G; Jamain, S; Jiang, X; Kassem, L; Kennedy, JL; Leboyer, M; Lewis, C; McGuffin, P; McMahon, FJ; Muglia, P; Nöthen, MM; Park, JH; Rietschel, M; Schulze, TG; Shugart, YY; Steele, CJ; Strauss, J; Vincent, JB; Wendland, JR | 1 |
Chen, RF; Huang, TL; Hung, YY; Lee, CT | 1 |
Jeanray, N; Martial, JA; Muller, M; Piot, A; Pruvot, B; Quiroz, Y; Voncken, A | 1 |
Bellivier, F; Etain, B; Geoffroy, PA; Henry, C | 1 |
Calabrese, JR; Chan, PK; Conroy, C; Fein, EB; Ganocy, SJ; Gao, K; Kemp, DE; Obral, S | 1 |
Coleman, MD; Devitt, A; Hill, EJ; Nagel, DA; O'Neil, JD; Torr, E; Woehrling, EK | 1 |
Gould, TD; Grahame, NJ; Halcomb, ME | 1 |
Chiu, IM; Chung, YF; Hsu, YC; Kao, CY; Lee, DC; Liu, JW | 1 |
D'Souza, UM; Farmer, AE; Haddley, K; Mcguffin, P; Powell, TR; Powell-Smith, G; Quinn, J; Schalkwyk, LC | 1 |
Golebiowska, J; Holuj, M; Kregiel, J; Popik, P; Rygula, R | 1 |
Sharma, S; Taliyan, R | 1 |
Akay, A; Baykara, B; Cevher, N; Guleryuz, H; Inal-Emiroglu, FN; Karabay, N; Resmi, H | 1 |
Hoffman, R; Iancu-Rubin, C | 1 |
Dong, GT; Feng, HL; Jiang, HQ; Jiang, HZ; Qi, Y; Ren, M; Wang, J; Wang, SY; Wang, TH; Wang, XD; Yang, YQ; Yin, X | 1 |
Duan, S; Han, Y; Li, X; Lou, H; Lu, Y; Zhen, X; Zhou, R; Zhu, L | 1 |
Babenko, VA; Gulyaev, MV; Pevzner, IB; Pirogov, YA; Plotnikov, EY; Savchenko, ES; Silachev, DN; Sukhikh, GT; Zorov, DB; Zorova, LD | 1 |
Callaerts, P; Del-Favero, J; Forero, D; Hens, K; Herteleer, L; Zwarts, L | 1 |
Chiu, CT; Chuang, DM; Leng, Y; Liao, HM; Linares, GR; Maric, D; Scheuing, L | 1 |
Baldwin, R; Lumley, L; Niquet, J; Norman, K; Suchomelova, L; Wasterlain, CG | 1 |
Chen, CC; Cheng, CY; Huang, MC; Lee, YL; Leu, SJ; Liu, HC; Liu, KJ; Shen, WW; Wu, YC; Yang, YY | 1 |
Callari, A; Colom, F; Goikolea, JM; Gonzalez de la Presa, B; Murru, A; Pacchiarotti, I; Pérez-Sola, V; Romero, S; Torra, M; Varo, C; Vieta, E | 1 |
Figueiredo, EG; Welling, LC; Welling, MS | 1 |
Han, J; Hong, SG; Kang, D; Kim, EJ; Lee, DK | 1 |
Harada, H; Jung, HS; Jung, YS; Kim, HY; Lee, DJ; Li, S; Muramatsu, T; Park, JH | 1 |
Bocci, G; Calabrò, PF; Carli, M; Fini, E; Natale, G; Scarselli, M | 1 |
5 review(s) available for valproic acid and lithium chloride
Article | Year |
---|---|
Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Cell Survival; Enoyl-CoA Hydratase; Humans; Intracellular Signaling Peptides and Proteins; Lithium Chloride; Mood Disorders; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA-Binding Proteins; RNA, Messenger; Transcription Factor AP-1; Valproic Acid | 2001 |
Identification of mood stabilizer-regulated genes by differential-display PCR.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carrier Proteins; Cerebral Cortex; Endoplasmic Reticulum Chaperone BiP; Gene Expression Profiling; Gene Expression Regulation; Heat-Shock Proteins; Humans; Lithium Chloride; Molecular Chaperones; Polymerase Chain Reaction; RNA, Messenger; Valproic Acid | 2001 |
Combination therapy for manic phases: a critical review of a common practice.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Chloride; Valproic Acid | 2012 |
Role of epigenetic reprogramming in hematopoietic stem cell function.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Proliferation; Cellular Reprogramming; Chromatin; Cytokines; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Hydroxamic Acids; Lithium Chloride; Valproic Acid | 2015 |
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?
Topics: Antimanic Agents; Bipolar Disorder; Brain Neoplasms; Glioblastoma; Humans; Lithium; Lithium Carbonate; Lithium Chloride; Pharmaceutical Preparations; Valproic Acid | 2023 |
7 trial(s) available for valproic acid and lithium chloride
Article | Year |
---|---|
Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Lithium Chloride; Male; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2000 |
Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Male; Olanzapine; Placebos; Quality of Life; Treatment Outcome; Valproic Acid | 2004 |
Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Blood Platelets; Enzyme Activation; Female; GTP-Binding Proteins; Humans; Lithium Chloride; Male; Protein Kinase C; Schizophrenia; Signal Transduction; Valproic Acid | 2005 |
A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression.
Topics: Adult; Affect; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Cognition; Female; Humans; Lithium Chloride; Male; Middle Aged; Neuropsychological Tests; Valproic Acid; Young Adult | 2008 |
Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Brain; Brain Mapping; Female; Humans; Image Processing, Computer-Assisted; Lithium Chloride; Longitudinal Studies; Magnetic Resonance Imaging; Male; Time Factors; Valproic Acid; Young Adult | 2010 |
Ziprasidone with adjunctive mood stabilizer in the maintenance treatment of bipolar I disorder: long-term changes in weight and metabolic profiles.
Topics: Adjuvants, Immunologic; Antipsychotic Agents; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Longitudinal Studies; Male; Metabolic Diseases; Metabolome; Piperazines; Psychiatric Status Rating Scales; Thiazoles; Valproic Acid | 2012 |
Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Chloride; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Triazines; Valproic Acid; Young Adult | 2012 |
75 other study(ies) available for valproic acid and lithium chloride
Article | Year |
---|---|
Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds.
Topics: Anticonvulsants; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Molecular Structure; Valproic Acid | 2004 |
Differential display PCR reveals increased expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase by lithium.
Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; 2',3'-Cyclic-Nucleotide Phosphodiesterases; Base Sequence; Carbamazepine; Gene Expression; Humans; Lithium Chloride; Molecular Sequence Data; Neuroglia; Oligodeoxyribonucleotides; Phosphoric Diester Hydrolases; Polymerase Chain Reaction; Sodium Chloride; Tumor Cells, Cultured; Valproic Acid | 1996 |
Protective effects of GABAergic drugs and other anticonvulsants in lithium-pilocarpine-induced status epilepticus.
Topics: Animals; Anticonvulsants; Baclofen; Clonazepam; Diazepam; Dizocilpine Maleate; Ethanol; GABA Agents; gamma-Aminobutyric Acid; Lithium Chloride; Male; Neuroprotective Agents; Pentobarbital; Phenobarbital; Phenytoin; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus; Valproic Acid | 1996 |
Mood stabilizers have differential effects on endogenous ADP ribosylation in C6 glioma cells.
Topics: Adenosine Diphosphate Ribose; Animals; Carbamazepine; Glioma; Lithium Chloride; Rats; Tumor Cells, Cultured; Valproic Acid | 1996 |
Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Topics: Animals; Bipolar Disorder; Blotting, Western; Carbamazepine; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Gene Expression; Hippocampus; Humans; Inositol; Intracellular Signaling Peptides and Proteins; Lithium Chloride; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Neurons; Protein Biosynthesis; Protein Kinase C; Proteins; Rabbits; Rats; Valproic Acid | 1996 |
Dissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluid.
Topics: Animals; Antimanic Agents; Female; gamma-Aminobutyric Acid; Glutamine; Hyponatremia; Lithium Chloride; Rats; Rats, Wistar; Valproic Acid | 1998 |
Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Topics: Animals; Antimanic Agents; Carbachol; Cells, Cultured; CHO Cells; Cricetinae; Cytidine Monophosphate; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Glycerophospholipids; Hippocampus; Intracellular Signaling Peptides and Proteins; Lithium Chloride; Membrane Proteins; Muscarinic Agonists; Myristoylated Alanine-Rich C Kinase Substrate; Phosphatidic Acids; Protein Kinase C; Proteins; Valproic Acid | 1998 |
Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.
Topics: Antimanic Agents; Base Sequence; Binding Sites; Consensus Sequence; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lithium Chloride; Neuroblastoma; Nuclear Proteins; Oligodeoxyribonucleotides; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Time Factors; Transcription Factor AP-1; Tumor Cells, Cultured; Valproic Acid | 1998 |
Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells.
Topics: Adenylyl Cyclases; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Humans; Kinetics; Lithium Chloride; Neuroblastoma; Phosphorylation; Signal Transduction; Tumor Cells, Cultured; Valproic Acid | 1999 |
Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos.
Topics: Animals; Antimanic Agents; Cyclic AMP Response Element-Binding Protein; Drug Administration Schedule; Gene Expression Regulation; Hippocampus; Lithium Chloride; Male; Nerve Tissue Proteins; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Transcription, Genetic; Valproic Acid | 1999 |
Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations.
Topics: Antimanic Agents; Astrocytoma; Bipolar Disorder; Brain; Brain Neoplasms; Carbamazepine; Dose-Response Relationship, Drug; Humans; Inositol; Lithium Chloride; Signal Transduction; Tritium; Tumor Cells, Cultured; Valproic Acid | 2000 |
Mood stabilizer augmentation with olanzapine in acutely manic children.
Topics: Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Bipolar Disorder; Child; Drug Therapy, Combination; Humans; Lithium Chloride; Male; Olanzapine; Pirenzepine; Sleep Stages; Valproic Acid; Weight Gain | 2000 |
Effects of lithium on the pharmacokinetics of valproate in rats.
Topics: Animals; Antimanic Agents; Cytochrome P-450 Enzyme System; Glucuronates; Glucuronosyltransferase; Lithium Chloride; Male; Metabolic Clearance Rate; Microsomes, Liver; Rats; Rats, Wistar; Time Factors; Valproic Acid | 2000 |
Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.
Topics: Animals; Brain; Dextroamphetamine; Inositol; Inositol Phosphates; Lithium Chloride; Magnetic Resonance Spectroscopy; Male; Models, Chemical; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Valproic Acid | 2000 |
A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency.
Topics: Antimanic Agents; Apoptosis; Caspase 3; Caspases; Humans; Ionophores; L-Lactate Dehydrogenase; Lithium Chloride; Neuroblastoma; Tumor Cells, Cultured; Valinomycin; Valproic Acid | 2000 |
Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Carbamazepine; Depressive Disorder; Female; Humans; Lithium Chloride; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Valproic Acid | 2001 |
Lamotrigine use in geriatric patients with bipolar depression.
Topics: Aged; Aged, 80 and over; Antimanic Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lithium Chloride; Male; Triazines; Valproic Acid | 2002 |
Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
Topics: Animals; Brain; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Chloride; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured; Valproic Acid | 2002 |
Lithium, but not valproate, induces the serine/threonine phosphatase activity of protein phosphatase 2A in the rat brain, without affecting its expression.
Topics: Animals; Brain; Enzyme Activation; Enzyme Induction; Gene Expression Regulation, Enzymologic; Lithium Chloride; Male; Phosphoprotein Phosphatases; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |
Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.
Topics: Adolescent; Adult; Antipsychotic Agents; Blood Platelets; Calcium Channels; Carbamazepine; Dextroamphetamine; Female; Humans; Lithium Chloride; Male; Middle Aged; Thrombin; Valproic Acid | 2003 |
Nonketotic hyperosmolar syndrome from olanzapine, lithium, and valproic acid cotreatment.
Topics: Adult; Benzodiazepines; Drug Therapy, Combination; Humans; Hyperglycinemia, Nonketotic; Lithium Chloride; Male; Olanzapine; Pirenzepine; Valproic Acid | 2003 |
Valproate-induced hyperammonemic encephalopathy.
Topics: Aggression; Anticonvulsants; Attention Deficit and Disruptive Behavior Disorders; Child; Diagnosis, Differential; Dibenzothiazepines; Disruptive, Impulse Control, and Conduct Disorders; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Electroencephalography; Humans; Hyperammonemia; Lithium Chloride; Liver Function Tests; Male; Neurotoxicity Syndromes; Quetiapine Fumarate; Valproic Acid | 2004 |
The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells.
Topics: Animals; Astrocytes; bcl-Associated Death Protein; Blotting, Western; Bromodeoxyuridine; Carrier Proteins; Cell Count; Cell Differentiation; Cells, Cultured; Cyclin D2; Cyclins; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; gamma-Aminobutyric Acid; Glial Fibrillary Acidic Protein; Glutamate Decarboxylase; Histones; Humans; Hydroxamic Acids; Immunohistochemistry; Interleukin-6; Leukemia Inhibitory Factor; Lithium Chloride; Neurons; Prosencephalon; Proto-Oncogene Proteins c-bcl-2; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Time Factors; Trans-Activators; Tretinoin; Tubulin; Valproic Acid | 2004 |
Cytokine production in bipolar affective disorder patients under lithium treatment.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Cytokines; Down-Regulation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium Chloride; Long-Term Care; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Recurrence; Valproic Acid | 2004 |
Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex.
Topics: Animals; Anticonvulsants; Antimanic Agents; beta-Adrenergic Receptor Kinases; Blotting, Western; Carbamazepine; Cytosol; Frontal Lobe; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 3; Lithium Chloride; Male; Rats; Rats, Inbred F344; Synaptic Membranes; Valproic Acid | 2007 |
Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids.
Topics: Adult; Antimanic Agents; Calcium; Calcium Signaling; Cell Line; Cell Nucleus; DNA, Mitochondrial; Female; Histamine; Humans; Hybrid Cells; Lithium Chloride; Male; Mitochondria; Valproic Acid | 2008 |
Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania.
Topics: Amphetamine; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Citrate (si)-Synthase; Disease Models, Animal; Drug Interactions; Hippocampus; Lithium Chloride; Male; Rats; Rats, Wistar; Valproic Acid | 2007 |
Lithium and valproate protect hippocampal slices against ATP-induced cell death.
Topics: Adenosine Triphosphate; Animals; Cell Death; Hippocampus; Lithium Chloride; Male; Rats; Rats, Wistar; Valproic Acid | 2007 |
Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Cognition Disorders; Diagnostic and Statistical Manual of Mental Disorders; Evaluation Studies as Topic; Female; Humans; Intelligence Tests; Lithium Chloride; Male; Memory; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Problem Solving; Valproic Acid; Verbal Learning | 2007 |
The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Topics: Animals; Antimanic Agents; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Lithium Chloride; Membrane Potentials; Neurons; Patch-Clamp Techniques; Potassium Chloride; Promoter Regions, Genetic; Rats; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection; Valproic Acid | 2009 |
The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.
Topics: Adjuvants, Immunologic; Administration, Oral; Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Central Nervous System Stimulants; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Lithium Chloride; Locomotion; Maze Learning; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Olanzapine; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Swimming; Valproic Acid | 2009 |
Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice.
Topics: Affect; Animals; Antimanic Agents; Chromatography, Gas; Chromatography, High Pressure Liquid; DNA; Gas Chromatography-Mass Spectrometry; Genes, bcl-2; Lithium Chloride; Male; Mice; Mice, Knockout; Neuronal Plasticity; Prefrontal Cortex; Pregnanolone; Pregnenolone; Rats; Rats, Inbred WKY; Reverse Transcriptase Polymerase Chain Reaction; Valproic Acid | 2008 |
Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
Topics: Adjuvants, Immunologic; Astrocytoma; beta Catenin; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Lithium Chloride; Protein D-Aspartate-L-Isoaspartate Methyltransferase; RNA, Messenger; RNA, Small Interfering; Time Factors; Up-Regulation; Valproic Acid | 2008 |
Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing.
Topics: Acrylamides; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Survival; Densitometry; Gene Expression; Humans; Hydroxyurea; Image Processing, Computer-Assisted; Immunohistochemistry; Lithium Chloride; Microscopy, Confocal; Models, Neurological; Nervous System Diseases; Neurons; Reverse Transcriptase Polymerase Chain Reaction; Teratogens; Tretinoin; Valproic Acid | 2008 |
Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
Topics: Adjuvants, Immunologic; Age Factors; Amyotrophic Lateral Sclerosis; Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Drug Therapy, Combination; Glycogen Synthase Kinase 3; Hindlimb Suspension; Humans; Lithium Chloride; Mice; Mice, Transgenic; Motor Activity; Muscle Strength; Mutation; Nervous System Diseases; Psychomotor Performance; Reflex; Rotarod Performance Test; Superoxide Dismutase; Survival Analysis; Valproic Acid | 2008 |
Effects of mood stabilizers on DNA damage in an animal model of mania.
Topics: Amphetamine; Animals; Antimanic Agents; Antioxidants; Bipolar Disorder; Central Nervous System Stimulants; Comet Assay; DNA Damage; Hippocampus; Lipid Peroxidation; Lithium Chloride; Male; Micronucleus Tests; Motor Activity; Oxidative Stress; Rats; Rats, Wistar; Valproic Acid | 2008 |
Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoid Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromogranin A; Enzyme Inhibitors; Gastrointestinal Neoplasms; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Immunoglobulin J Recombination Signal Sequence-Binding Protein; Lithium Chloride; Luciferases; Lung Neoplasms; Receptor, Notch1; Valproic Acid | 2009 |
The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
Topics: Antimanic Agents; Apoptosis; Cell Line, Tumor; Gene Expression Profiling; Gene Silencing; Homeodomain Proteins; Humans; Lithium Chloride; Neuroblastoma; Staurosporine; Up-Regulation; Valproic Acid | 2009 |
Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm.
Topics: Analysis of Variance; Animals; Antimanic Agents; Behavior, Animal; Brain; Central Nervous System Stimulants; Conditioning, Operant; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Combinations; Lithium Chloride; Male; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Valproic Acid | 2009 |
Expression of mitochondrial complex I subunit gene NDUFV2 in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Antimanic Agents; Bipolar Disorder; Cell Line, Transformed; Female; Gene Expression; Genotype; Humans; Lithium Chloride; Lymphocytes; Male; Middle Aged; NADH Dehydrogenase; RNA, Messenger; Schizophrenia; Statistics, Nonparametric; Up-Regulation; Valproic Acid | 2009 |
Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity.
Topics: Animals; Antimanic Agents; Carbamazepine; Cell Culture Techniques; DNA, Complementary; GAP-43 Protein; Growth Cones; Humans; Indoles; Lamotrigine; Lithium Chloride; Mice; Mice, Knockout; Phosphatidylinositols; Prolyl Oligopeptidases; Rats; Serine Endopeptidases; Thiazolidines; Triazines; Valproic Acid | 2009 |
Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
Topics: Cell Division; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lithium Chloride; Receptor, Notch1; Thyroid Neoplasms; Tumor Cells, Cultured; Up-Regulation; Valproic Acid | 2010 |
Differential modulation of intracellular Ca2+ responses in B lymphoblasts by mood stabilizers.
Topics: Adult; Antimanic Agents; B-Lymphocytes; Bipolar Disorder; Calcium; Cell Line, Transformed; Drug Interactions; Enzyme Inhibitors; Female; Humans; Intracellular Fluid; Lipopolysaccharides; Lithium Chloride; Male; Middle Aged; Thapsigargin; Valproic Acid | 2010 |
Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Antimanic Agents; Carbamazepine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Fructose; Injections, Intraperitoneal; Lamotrigine; Lithium Chloride; Male; Mice; Mice, Inbred DBA; Reflex, Startle; Topiramate; Triazines; Valproic Acid | 2009 |
Evaluation of the effects of propylisopropylacetic acid (PIA) on neuronal growth cone morphology.
Topics: Actins; Animals; Animals, Newborn; Antimanic Agents; Carbamazepine; Cytoskeleton; Ganglia, Spinal; Gene Expression; Growth Cones; Immunohistochemistry; Lithium Chloride; Neurons; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Stereoisomerism; T-Lymphocytes; Valproic Acid | 2009 |
Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
Topics: Amygdala; Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hippocampus; Lithium Chloride; Male; Motor Activity; Ouabain; Rats; Rats, Wistar; Valproic Acid | 2010 |
Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Topics: Adolescent; Age Factors; Antimanic Agents; Bipolar Disorder; Child; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Male; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Valproic Acid | 2010 |
Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania.
Topics: Analysis of Variance; Animals; Antimanic Agents; Bipolar Disorder; Brain; Catalase; Disease Models, Animal; Drug Interactions; Gene Expression Regulation, Enzymologic; Injections, Intraventricular; Lithium Chloride; Male; Ouabain; Protein Carbonylation; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Valproic Acid | 2011 |
Lithium neurotoxicity at normal serum levels.
Topics: Antimanic Agents; Bipolar Disorder; Humans; Lithium Chloride; Male; Middle Aged; Neurotoxicity Syndromes; Psychomotor Performance; Valproic Acid | 2010 |
Commentary: the Bipolar Affective Disorder: Lithium/Anticonvulsant Evaluation (BALANCE) study.
Topics: Anticonvulsants; Bipolar Disorder; Humans; Lithium Chloride; Randomized Controlled Trials as Topic; Valproic Acid | 2010 |
A much needed BALANCE.
Topics: Anticonvulsants; Bipolar Disorder; Drug Therapy, Combination; Humans; Lithium Chloride; Valproic Acid | 2010 |
Valproic acid inhibits neurosphere formation by adult subventricular cells by a lithium-sensitive mechanism.
Topics: Adult Stem Cells; Animals; Anticonvulsants; Antimanic Agents; Basic Helix-Loop-Helix Transcription Factors; Cell Proliferation; Cells, Cultured; Cerebral Ventricles; CREB-Binding Protein; Cyclic AMP Response Element-Binding Protein; DNA; Drug Antagonism; Early Growth Response Protein 1; Female; Histone Deacetylase Inhibitors; Lithium Chloride; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Multipotent Stem Cells; Neurogenesis; Phosphorylation; Transcription, Genetic; Valproic Acid | 2011 |
Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations.
Topics: Astrocytes; Brain-Derived Neurotrophic Factor; Cell Count; Cell Line, Tumor; Humans; Lithium Chloride; Valproic Acid | 2012 |
Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats.
Topics: Animals; Carbamazepine; Choice Behavior; Dose-Response Relationship, Drug; Eating; Impulsive Behavior; Lithium Chloride; Male; Rats; Rats, Wistar; Reaction Time; Serial Learning; Valproic Acid | 2012 |
Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder.
Topics: Ankyrins; Antidepressive Agents; Asian People; Bipolar Disorder; Cell Line, Transformed; Cytokines; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Gene Frequency; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Lectins; Lithium Chloride; Male; Membrane Transport Proteins; Meta-Analysis as Topic; Polymorphism, Single Nucleotide; Receptors, Prostaglandin; RNA, Messenger; Time Factors; Valproic Acid; White People | 2013 |
Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers.
Topics: Adult; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Female; Humans; Lithium Chloride; Male; Middle Aged; Protein Kinases; Retrospective Studies; Valproic Acid; Young Adult | 2012 |
A panel of biological tests reveals developmental effects of pharmaceutical pollutants on late stage zebrafish embryos.
Topics: Animals; Behavior, Animal; Caffeine; Carbamazepine; Embryo, Nonmammalian; Gene Expression Regulation, Developmental; Heart Rate; Lithium Chloride; Motor Activity; Pentobarbital; Psychotropic Drugs; Theophylline; Toxicity Tests; Valproic Acid; Water Pollutants, Chemical; Zebrafish | 2012 |
Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development.
Topics: Cell Culture Techniques; Cell Cycle; Cell Line; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation; Humans; Lithium Chloride; Molecular Sequence Annotation; Neurogenesis; Octamer Transcription Factor-3; Phenotype; Reproducibility of Results; Stage-Specific Embryonic Antigens; Valproic Acid | 2013 |
Lithium, but not valproate, reduces impulsive choice in the delay-discounting task in mice.
Topics: Animals; Antimanic Agents; Choice Behavior; Conditioning, Operant; Female; Impulsive Behavior; Lithium Chloride; Male; Mice; Mice, Inbred Strains; Valproic Acid | 2013 |
The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
Topics: Animals; Antimanic Agents; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Chromatin Immunoprecipitation; Electrophoretic Mobility Shift Assay; Embryonic Stem Cells; Fibroblast Growth Factor 1; Flow Cytometry; Glycogen Synthase Kinase 3; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Immunohistochemistry; Lithium Chloride; Mice; Neural Stem Cells; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Small Interfering; Transcriptional Activation; Valproic Acid | 2013 |
Mood-stabilizers differentially affect housekeeping gene expression in human cells.
Topics: Aged; Antimanic Agents; Cell Line, Transformed; Depression; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Genes, Essential; Humans; Lithium Chloride; Lymphocytes; Male; Middle Aged; RNA, Messenger; Time Factors; Valproic Acid | 2014 |
Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats.
Topics: Animals; Antimanic Agents; Cognition; Cues; Electroshock; Judgment; Lithium Chloride; Male; Rats; Rats, Sprague-Dawley; Valproic Acid | 2015 |
Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Brain; Brain-Derived Neurotrophic Factor; Cognition Disorders; Drug Synergism; Drug Therapy, Combination; Glutathione; Glycogen Synthase Kinase 3; Histone Deacetylase Inhibitors; Insulin; Lithium Chloride; Malondialdehyde; Memory; Memory Disorders; Neuroprotective Agents; Nitrates; Nitrites; Rats, Wistar; Spatial Learning; Streptozocin; Valproic Acid | 2015 |
Decreased right hippocampal volumes and neuroprogression markers in adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Disease Progression; Female; Functional Laterality; Hippocampus; Humans; Lithium Chloride; Magnetic Resonance Imaging; Male; Nerve Growth Factor; Statistics as Topic; Valproic Acid; Young Adult | 2015 |
Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.
Topics: Amyotrophic Lateral Sclerosis; Animals; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Gene Expression Regulation; Humans; Lithium Chloride; Mice; Mice, Transgenic; Motor Neurons; Neuroprotective Agents; Receptors, Notch; RNA, Small Interfering; Signal Transduction; Spinal Cord; Superoxide Dismutase; Transfection; Valproic Acid | 2015 |
Mice heterozygous for cathepsin D deficiency exhibit mania-related behavior and stress-induced depression.
Topics: Adaptation, Ocular; Animals; Antidepressive Agents; Bipolar Disorder; Cathepsin D; Corticosterone; Depression; Dextroamphetamine; Disease Models, Animal; Exploratory Behavior; Female; Food Preferences; Hyperkinesis; Lithium Chloride; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Ceroid-Lipofuscinoses; Sleep Wake Disorders; Swimming; Valproic Acid | 2015 |
Protection of Neurovascular Unit Cells with Lithium Chloride and Sodium Valproate Prevents Brain Damage in Neonatal Ischemia/Hypoxia.
Topics: Animals; Animals, Newborn; Brain Injuries; Hypoxia; Hypoxia-Ischemia, Brain; Lithium Chloride; Rats; Valproic Acid | 2016 |
Mood stabilizing drugs regulate transcription of immune, neuronal and metabolic pathway genes in Drosophila.
Topics: Animals; Antimanic Agents; Cell Line; Drosophila; Head; Immune System; Lithium Chloride; Metabolic Networks and Pathways; Microarray Analysis; Neurons; Transcription, Genetic; Valproic Acid | 2016 |
Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.
Topics: Animals; Antimanic Agents; Cytokines; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Administration Schedule; Female; Gene Expression; Huntingtin Protein; Huntington Disease; Lithium Chloride; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phosphopyruvate Hydratase; Proto-Oncogene Proteins c-kit; Receptors, Cytokine; Up-Regulation; Valproic Acid | 2016 |
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
Topics: Animals; Anticonvulsants; Brain; Cholinergic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ketamine; Learning Disabilities; Lithium Chloride; Male; Maze Learning; Midazolam; N-Methylscopolamine; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid | 2016 |
Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Arthritis, Experimental; Cattle; Cell Differentiation; Cell Polarity; Cytokines; Dendritic Cells; Inflammation; Interleukin-10; Interleukin-6; Interleukin-8; Lipid Metabolism; Lipopolysaccharides; Lithium Chloride; Mice; Monocytes; Th17 Cells; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Valproic Acid | 2017 |
A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Female; Humans; Lithium Chloride; Male; Middle Aged; Psychiatric Status Rating Scales; Saliva; Therapeutic Equivalency; Valproic Acid | 2017 |
Traumatic Brain Injury and Mood Stabilizers: Recent Cumulative Evidence.
Topics: Antimanic Agents; Brain Injuries, Traumatic; Humans; Lithium Chloride; Valproic Acid | 2017 |
Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers.
Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; HEK293 Cells; Hippocampus; Humans; Ion Channel Gating; Lithium Chloride; Neurons; Potassium Channels, Tandem Pore Domain; Valproic Acid | 2017 |
Activation of Wnt signalling reduces the population of cancer stem cells in ameloblastoma.
Topics: Ameloblastoma; Animals; beta Catenin; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Size; Down-Regulation; Humans; Lithium Chloride; Mice; Mice, Nude; Neoplastic Stem Cells; SOXB1 Transcription Factors; Valproic Acid; Wnt Signaling Pathway | 2021 |